|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
|
PT1031347E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
|
|
ATE216875T1
(de)
|
1999-01-27 |
2002-05-15 |
Idea Ag |
Nichtinvasive impfung durch die haut
|
|
WO2001001962A1
(en)
*
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US6248353B1
(en)
*
|
1999-12-10 |
2001-06-19 |
Dade Behring Inc. |
Reconstitution of purified membrane proteins into preformed liposomes
|
|
DK1345959T3
(da)
*
|
2000-11-20 |
2011-09-05 |
Univ Illinois |
Membranscaffoldproteiner
|
|
US7592008B2
(en)
*
|
2000-11-20 |
2009-09-22 |
The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois |
Membrane scaffold proteins
|
|
US7622437B2
(en)
*
|
2000-11-20 |
2009-11-24 |
The Board Of Trustees Of The University Of Illinois |
Tissue factor compositions and methods
|
|
US7083958B2
(en)
*
|
2000-11-20 |
2006-08-01 |
The Board Of Trustees Of The University Of Illinois |
Membrane scaffold proteins
|
|
US6596543B2
(en)
*
|
2001-03-22 |
2003-07-22 |
Dade Behring Inc. |
Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
|
|
US7015193B2
(en)
*
|
2001-04-20 |
2006-03-21 |
University Of Vermont |
Compositions and methods to control bleeding
|
|
WO2003075889A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
US20040105881A1
(en)
*
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
US20050032113A1
(en)
*
|
2003-07-17 |
2005-02-10 |
Mitsubishi Pharma Corporation |
Membrane protein library for proteome analysis and method for preparing same
|
|
KR101076578B1
(ko)
|
2004-06-23 |
2011-10-24 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
2입자 착물을 이용한 생물학적 분자의 검출을 위한 방법 및조성물
|
|
US7148067B2
(en)
*
|
2004-08-31 |
2006-12-12 |
The Board Of Trustees Of The University Of Illinois |
Thromboplastin reagents
|
|
JP2008519784A
(ja)
*
|
2004-11-12 |
2008-06-12 |
イデア アクチェンゲゼルシャフト |
皮膚状態の治療における拡張表面凝集体
|
|
US20080260858A1
(en)
*
|
2005-02-16 |
2008-10-23 |
The Board Of Trustees Of The University Of Illnois |
Universal Procoagulant
|
|
AT501650A1
(de)
*
|
2005-02-22 |
2006-10-15 |
Technoclone Ges M B H |
Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
|
|
JP2008531692A
(ja)
*
|
2005-03-04 |
2008-08-14 |
ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ |
凝固及び線維素溶解カスケードのモジュレーター
|
|
US20080248565A1
(en)
*
|
2007-03-01 |
2008-10-09 |
Invitrogen Corporation |
Isolated phospholipid-protein particles
|
|
US20070117179A1
(en)
*
|
2005-09-27 |
2007-05-24 |
Invitrogen Corporation |
In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
|
|
JP2007106679A
(ja)
*
|
2005-10-11 |
2007-04-26 |
Shino Test Corp |
血液凝固反応促進剤
|
|
EP1939218A1
(en)
*
|
2006-12-29 |
2008-07-02 |
Thrombotargets Europe, S.L. |
Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
|
|
US7943168B2
(en)
|
2007-03-05 |
2011-05-17 |
Washington University |
Nanoparticle delivery systems comprising a hydrophobic core and a lipid/surfactant layer comprising a membrane-lytic peptide
|
|
CA2700808C
(en)
|
2007-09-27 |
2017-11-14 |
Immunovaccine Technologies Inc. |
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
|
|
EP2062661A1
(en)
*
|
2007-09-28 |
2009-05-27 |
Proviron Holding |
Organic de-icer removal
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
WO2009046194A2
(en)
*
|
2007-10-05 |
2009-04-09 |
The Board Of Trustees Of The University Of Illinois |
Fibrin sealant
|
|
WO2009061697A1
(en)
|
2007-11-09 |
2009-05-14 |
The Board Of Trustees Of The University Of Illinois |
Anticoagulant antagonist and hemophilia procoagulant
|
|
US20090220588A1
(en)
*
|
2008-02-21 |
2009-09-03 |
Massachusetts Institute Of Technology |
Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
|
|
ES2524699T3
(es)
|
2008-06-05 |
2014-12-11 |
Immunovaccine Technologies Inc. |
Composiciones que comprenden liposomas, un antígeno, un polinucleótido y un vehículo que comprende una fase continua de una sustancia hidrófoba
|
|
US8956600B2
(en)
|
2009-08-10 |
2015-02-17 |
Taiwan Liposome Co. Ltd. |
Ophthalmic drug delivery system containing phospholipid and cholesterol
|
|
US10525152B2
(en)
|
2009-10-09 |
2020-01-07 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
|
US10894098B2
(en)
|
2012-04-09 |
2021-01-19 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
|
US12419839B2
(en)
|
2009-10-09 |
2025-09-23 |
Signablok, Inc. |
Methods and compositions for targeted delivery of protein fragments
|
|
KR101458315B1
(ko)
|
2013-07-19 |
2014-11-04 |
전북대학교산학협력단 |
표면 개질된 리포좀 및 그 제조방법
|
|
JP6626761B2
(ja)
|
2016-03-30 |
2019-12-25 |
シスメックス株式会社 |
プロトロンビン時間測定用試薬およびその製造方法
|
|
JP6652873B2
(ja)
*
|
2016-03-30 |
2020-02-26 |
シスメックス株式会社 |
プロトロンビン時間測定用試薬、その製造方法およびプロトロンビン時間の測定方法
|
|
WO2019200240A1
(en)
|
2018-04-13 |
2019-10-17 |
Board Of Regents, The University Of Texas System |
Transmembrane stem cell factor (tm-scf) lipid nanocarriers and methods of use thereof
|
|
EP3819640B1
(en)
*
|
2018-07-06 |
2025-06-18 |
PHC Corporation |
Liposome-containing liquid reagent for measuring blood coagulation ability
|
|
JP7153519B2
(ja)
|
2018-09-28 |
2022-10-14 |
シスメックス株式会社 |
凝固時間測定用試薬及びその製造方法、試薬キット及び凝固時間の測定方法
|